Supernus Pharmaceuticals
SUPN
#4509
Rank
HK$19.25 B
Marketcap
HK$330.68
Share price
-2.11%
Change (1 day)
-11.48%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2026 (TTM): -HK$0.94 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.83 Billion. In 2025 the company made an earning of -HK$0.35 Billion a decrease over its 2024 earnings that were of HK$0.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.94 Billion168.13%
2025 -HK$0.35 Billion-155.5%
2024 HK$0.62 B1446.62%
2023 HK$40.68 M-92.36%
2022 HK$0.53 B-29.8%
2021 HK$0.75 B-49.79%
2020 HK$1.50 B12.99%
2019 HK$1.33 B7.58%
2018 HK$1.24 B54.9%
2017 HK$0.80 B84.25%
2016 HK$0.43 B202.27%
2015 HK$0.14 B-462.04%
2014 -HK$39.77 Million-94%
2013 -HK$0.67 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$205.66 B-21,967.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$63.85 B-6,889.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$263.63 B-28,131.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$93.46 B-10,037.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
-HK$1.67 Billion 76.92%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
HK$12.43 B-1,422.50%๐Ÿ‡บ๐Ÿ‡ธ USA